Zacks Investment Research on MSN
ImmunityBio shares surge on updated durable lymphoma study results
Shares of ImmunityBio IBRX surged 39.8% on Friday and added a further 9.4% in after-hours trading after the company reported ...
Pharmacy shelves and online marketplaces these days are crowded with products that promise to “boost” your immunity. From ...
Clinical Trials Arena on MSN
ImmunityBio’s allogeneic CD19 cell therapy shows complete response beyond 15 months
ImmunityBio’s stock is up after its off-the-shelf allogeneic CD19 chimeric antigen receptor natural killer cell therapy ...
Mulethi, or liquorice root, in the morning can boost overall immunity. Here is how and why you should consume it.
Scientists have uncovered a troubling role for a vitamin A byproduct in cancer, which appears to help tumours slip past the ...
From sleep, anxiety to vitamin deficiencies, there seems to be a squishy, tasty solution for them all. But doctors sound a ...
A viral video of a self-identified physician being prevented from aiding Renee Nicole Good has sparked outrage. Legal experts ...
Beyond death, complications include pneumonia, seizures, blindness in malnourished individuals (especially young children), ...
Frequent infections may stem from poor water quality. Find out which tests help you identify potential health contaminants.
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
ImmunityBio, Inc. ( IBRX) 44th Annual J.P. Morgan Healthcare Conference January 11, 2026 7:00 PM EST ...
Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results